As commercial real estate distress continues to play out, attorneys are seeing lenders adopt new strategies to save or reduce their exposure to troubled assets, sometimes working in tandem with investors looking to purchase such loans.

The troubled assets are not limited to the office sector, although that has been the sector that national and regional banks have all but shunned, under pressure from regulators. Life sciences real estate, for which there was much appetite during the pandemic, is dealing with an abundance of supply as the market for such specialized facilities finds its footing.

Zev Gewurz and Frank Ditta discuss how investors and lenders can navigate distress in the commercial real estate market, including in the life sciences sector, with Law360. Click here to read.